0 products, total $0.+86-400-890-9989      Login |  Register 中文한국어

Browse By Molecule:

Your Position: Home > Gene Products > Human cDNA Clones > Human CD44 Gene cDNA Clone / ORF Clone

Human CD44 Gene cDNA Clone / ORF Clone

Catalog Vector (Price) Quantity In Stock Operation
HG12211-G





  YES

*  pCMV vectors are ALL featured with a CMV promoter and a hygromycin-resistance (hygro) gene. These plasmids can be used directly in mammalian cell expression. Learn more about pCMV vectors.
    Notice: Additional handling time(2-3 weeks) may be required if a pCMV vector is selected.

CD44 cDNA Clone Datasheet

 

CD44 cDNA Clone Product Information

Gene Bank Ref.ID: BC004372

cDNA Size:

2100

Gene Synonym:

IN; LHR; MC56; MDU2; MDU3; MIC4; Pgp1; CDW44; CSPG8; HCELL; HUTCH-I; ECMR-III;CD44

Source: Human

CD44 cDNA Clone Description

cDNA Description:

ORF Clone of Homo sapiens CD44 molecule (Indian blood group) DNA.

Vector: Cloning Vector: pGEM-T Vector

Expression Vectors: pCMV/hygro, pCMV/hygro-Myc, pCMV/hygro-His, pCMV/hygro-HA, pCMV/hygro-FLAG

Sequence Description: Identical with the Gene Bank Ref.ID sequence.

CD44 cDNA Clone Shipping

  1. 5-10μg Plasmid DNA is shipped on Whatman FTA elute card (Cat. No.: WB120410) at room temperature.
  2. It would take 7-14 days for delivery typically. For bulk orders, additional 1-2 weeks would be needed.

CD44 cDNA Clone Usage Protocol

  1. Cut along the circle edge of the spot (arrow points to) to get the filter paper.
  2. Transfer the filter paper to a 1.5ml microfuge tube containing 150-200 μl of sterile H2O Ensure the filter is completely immersed in the H2O by briefly centrifuging the tube for 10 seconds.
  3. Transfer the tube to incubation at 95℃ for 15-30 min.
  4. At the end of the incubation pulse vortex, or gently tap the tube.
  5. Briefly centrifuge for 30 seconds, to separate the matrix from the elute. The elute now contains the purified DNA.

CD44 cDNA Clone Sequence and Quality Control

Sequence:

1        ATGGACAAGT TTTGGTGGCA CGCAGCCTGG GGACTCTGCC TCGTGCCGCT GAGCCTGGCG
61       CAGATCGATT TGAATATAAC CTGCCGCTTT GCAGGTGTAT TCCACGTGGA GAAAAATGGT
121      CGCTACAGCA TCTCTCGGAC GGAGGCCGCT GACCTCTGCA AGGCTTTCAA TAGCACCTTG
181      CCCACAATGG CCCAGATGGA GAAAGCTCTG AGCATCGGAT TTGAGACCTG CAGGTATGGG
241      TTCATAGAAG GGCATGTGGT GATTCCCCGG ATCCACCCCA ACTCCATCTG TGCAGCAAAC
301      AACACAGGGG TGTACATCCT CACATCCAAC ACCTCCCAGT ATGACACATA TTGCTTCAAT
361      GCTTCAGCTC CACCTGAAGA AGATTGTACA TCAGTCACAG ACCTGCCCAA TGCCTTTGAT
421      GGACCAATTA CCATAACTAT TGTTAACCGT GATGGCACCC GCTATGTCCA GAAAGGAGAA
481      TACAGAACGA ATCCTGAAGA CATCTACCCC AGCAACCCTA CTGATGATGA CGTGAGCAGC
541      GGCTCCTCCA GTGAAAGGAG CAGCACTTCA GGAGGTTACA TCTTTTACAC CTTTTCTACT
601      GTACACCCCA TCCCAGACGA AGACAGTCCC TGGATCACCG ACAGCACAGA CAGAATCCCT
661      GCTACCAGTA CGTCTTCAAA TACCATCTCA GCAGGCTGGG AGCCAAATGA AGAAAATGAA
721      GATGAAAGAG ACAGACACCT CAGTTTTTCT GGATCAGGCA TTGATGATGA TGAAGATTTT
781      ATCTCCAGCA CCATTTCAAC CACACCACGG GCTTTTGACC ACACAAAACA GAACCAGGAC
841      TGGACCCAGT GGAACCCAAG CCATTCAAAT CCGGAAGTGC TACTTCAGAC AACCACAAGG
901      ATGACTGATG TAGACAGAAA TGGCACCACT GCTTATGAAG GAAACTGGAA CCCAGAAGCA
961      CACCCTCCCC TCATTCACCA TGAGCATCAT GAGGAAGAAG AGACCCCACA TTCTACAAGC
1021     ACAATCCAGG CAACTCCTAG TAGTACAACG GAAGAAACAG CTACCCAGAA GGAACAGTGG
1081     TTTGGCAACA GATGGCATGA GGGATATCGC CAAACACCCA GAGAAGACTC CCATTCGACA
1141     ACAGGGACAG CTGCAGCCTC AGCTCATACC AGCCATCCAA TGCAAGGAAG GACAACACCA
1201     AGCCCAGAGG ACAGTTCCTG GACTGATTTC TTCAACCCAA TCTCACACCC CATGGGACGA
1261     GGTCATCAAG CAGGAAGAAG GATGGATATG GACTCCAGTC ATAGTACAAC GCTTCAGCCT
1321     ACTGCAAATC CAAACACAGG TTTGGTGGAA GATTTGGACA GGACAGGACC TCTTTCAATG
1381     ACAACGCAGC AGAGTAATTC TCAGAGCTTC TCTACATCAC ATGAAGGCTT GGAAGAAGAT
1441     AAAGACCATC CAACAACTTC TACTCTGACA TCAAGCAATA GGAATGATGT CACAGGTGGA
1501     AGAAGAGACC CAAATCATTC TGAAGGCTCA ACTACTTTAC TGGAAGGTTA TACCTCTCAT
1561     TACCCACACA CGAAGGAAAG CAGGACCTTC ATCCCAGTGA CCTCAGCTAA GACTGGGTCC
1621     TTTGGAGTTA CTGCAGTTAC TGTTGGAGAT TCCAACTCTA ATGTCAATCG TTCCTTATCA
1681     GGAGACCAAG ACACATTCCA CCCCAGTGGG GGGTCCCATA CCACTCATGG ATCTGAATCA
1741     GATGGACACT CACATGGGAG TCAAGAAGGT GGAGCAAACA CAACCTCTGG TCCTATAAGG
1801     ACACCCCAAA TTCCAGAATG GCTGATCATC TTGGCATCCC TCTTGGCCTT GGCTTTGATT
1861     CTTGCAGTTT GCATTGCAGT CAACAGTCGA AGAAGGTGTG GGCAGAAGAA AAAGCTAGTG
1921     ATCAACAGTG GCAATGGAGC TGTGGAGGAC AGAAAGCCAA GTGGACTCAA CGGAGAGGCC
1981     AGCAAGTCTC AGGAAATGGT GCATTTGGTG AACAAGGAGT CGTCAGAAAC TCCAGACCAG
2041     TTTATGACAG CTGATGAGAC AAGGAACCTG CAGAATGTGG ACATGAAGAT TGGGGTGTAA

 

Quality Control:cDNA sequencing results is available upon request.

 

CD44 related areas, pathways, and other information